Skip to main content
Article
PO-03-217 Suture closure after vein access for cardiac procedures (safe-vein) trial: A randomized, prospective study of the safety and efficacy of Perclose ProGlide closure device compared with a conventional closure strategy in large bore venous access procedures
Heart rhythm
  • Mahmoud Ali, Advocate Aurora Health
  • Faisal Masood, Advocate Aurora Health
  • Lynn Erickson, Advocate Aurora Health
  • Jim Kanani, Advocate Aurora Health
  • James Adefisoye, Advocate Aurora Health
  • Sara Walczak, Advocate Aurora Health
  • Tarek Ajam, Advocate Aurora Health
  • Andy Kieu, Advocate Aurora Health
  • Mohammed Premjee, Advocate Aurora Health
  • Hammam Shereef, Advocate Aurora Health
  • M Fuad Jan, Advocate Aurora Health
  • Suhail Q Allaqaband, Advocate Aurora Health
  • Tanvir Bajwa, Advocate Aurora Health
  • Jayant Khitha, Advocate Aurora Health
  • Jodi Zilinski, Advocate Aurora Health
  • Arshad Jahangir, Advocate Aurora Health
  • Mohamed Djelmami-Hani, Advocate Aurora Health
  • Jasbir Sra, Advocate Aurora Health
  • Imran Niazi, Advocate Aurora Health
  • M Eyman Mortada, Advocate Aurora Health
Scholarly Activity Date
9-1-2023
Type
Abstract
Citation Information
Ali M, Masood F, Erickson L, et al. PO-03-217 Suture closure after vein access for cardiac procedures (safe-vein) trial: A randomized, prospective study of the safety and efficacy of Perclose ProGlide closure device compared with a conventional closure strategy in large bore venous access procedures. Heart Rhythm. 2023;20(9):e148-e149. doi:10.1016/j.hrthm.2023.07.017